Oil volatility and inflation fears follow as markets price delay in crude flows. The S&P 500, Nasdaq and Dow all showed softness in recent sessions, with volatility staying elevated. Bullish AbCellera wins ‘off the chart’ trial signal... shares surge on women’s health upside AbCellera’s phase 2 results for a women’s health treatment drew a “beyond” assessment versus its most optimistic scenario, boosting confidence in challenging larger pharma rivals. Bank of Korea deputy governor signals more hikes... inflation risk still not contained Markets and inflation are moving with central banks—Korea and Australia signal the path of interest rates, with policy risk and inflation sensitivity driving investor caution. AbCellera women’s health data tops ‘most aggressive upside’... Astellas and Bayer on notice Clinical and biotech momentum is strong—AbCellera’s trial results and women’s health upside narrative are moving biotech stocks, while also pressuring larger pharma rivals.